Shock therapy, formally called electroconvulsive therapy (ECT), is a medical procedure that sends brief electrical pulses through the brain to trigger a controlled seizure. It is one of the most effective treatments available for severe depression, with 70% to 90% of patients with treatment-resistant depression responding to it. Despite its reputation, modern ECT looks nothing like the dramatic portrayals in movies. It is performed under general anesthesia, takes only a few minutes per session, and remains a standard treatment in psychiatric medicine worldwide.
What ECT Treats
ECT is most commonly used for major depression that hasn’t responded to at least two different types of antidepressant medication. When someone reaches that point, often called treatment-resistant depression, the odds of yet another medication working drop considerably. ECT changes the equation: response rates of 70% to 90% make it far more effective than switching to a third or fourth drug.
Beyond depression, ECT is considered a first-line treatment for several psychiatric emergencies. Catatonia, a condition where a person becomes unresponsive and unable to move or speak, often improves rapidly with ECT, especially when sedative medications don’t fully work. It is also a front-line option for a dangerous form of mania called delirious mania and for neuroleptic malignant syndrome, a rare but life-threatening reaction to psychiatric medications. ECT can also be used for severe bipolar episodes, certain forms of psychosis, and schizophrenia that hasn’t responded to medication.
How the Procedure Works
A typical course of ECT involves 6 to 12 sessions, given two or three times per week over three to four weeks. Each session lasts only a few minutes from start to finish, though you’ll spend additional time in a recovery area afterward.
Before the electrical stimulus is delivered, an anesthesiologist puts you under with a short-acting anesthetic. You’re also given a muscle relaxant to prevent your body from physically convulsing during the seizure. The most common combination used in the United States is a fast-acting barbiturate paired with a rapid muscle relaxant, both of which wear off within minutes. You are completely unconscious during the procedure and feel no pain.
Once you’re asleep and your muscles are relaxed, the psychiatrist places electrodes on your scalp and delivers a controlled electrical current for a few seconds. This triggers a seizure in the brain that typically lasts 30 to 60 seconds. Medical staff monitor your brain activity, heart rate, and oxygen levels throughout. When the anesthesia wears off, usually within 10 to 15 minutes, you wake up in a recovery area. Most people feel groggy or slightly confused for the first hour or so.
Electrode Placement Matters
There are two main ways to position the electrodes. In unilateral placement, both electrodes go on the same side of the head, typically the right side. In bilateral placement, one electrode sits on each temple. Bilateral ECT was long thought to be more effective, but research comparing the two approaches has found that moderately dosed unilateral ECT produces equivalent improvements in mood while causing fewer cognitive side effects, particularly less impact on verbal memory and autobiographical memory. For this reason, many clinicians now start with unilateral placement and switch to bilateral only if the patient doesn’t respond.
Why It Works
The honest answer is that scientists still don’t fully understand the mechanism. But several well-supported theories have emerged. The leading explanation centers on neuroplasticity: the seizure appears to stimulate the growth of new brain cells and strengthen connections between existing ones, particularly in the hippocampus, a brain region involved in mood regulation and memory. After ECT, levels of a key growth-promoting protein called BDNF rise in the hippocampus, along with increases in blood vessel growth factors that support new neural tissue.
ECT also rebalances several chemical messenger systems in the brain. It boosts serotonin transmission, the same system targeted by common antidepressants but through a different pathway. It increases the brain’s inhibitory signaling, which helps calm overactive neural circuits, and activates the dopamine system, which plays a role in motivation and pleasure. There’s also growing evidence that it enhances a type of signaling involved in building new synapses, the junctions where brain cells communicate with each other. In short, ECT appears to do many of the things antidepressants aim to do, but more broadly and more rapidly.
Memory Loss and Other Side Effects
Memory disruption is the most discussed side effect, and it’s a real concern. About 60% of patients report some degree of memory problems during or after a course of ECT. Of those, roughly 40% say the problems lasted anywhere from several weeks to several years.
The pattern is fairly predictable. New learning ability, your capacity to form and retain new memories, is impaired immediately after treatment. But objective testing shows that this recovers to baseline levels within about 14 days of completing the course. Beyond that two-week mark, there is no evidence of ongoing impairment in forming new memories.
Retrograde memory loss, meaning gaps in memories from before or during the treatment period, is a different story. Some memories from the weeks surrounding ECT may never fully return. For most people, this type of memory loss improves significantly within six months, but a subset of patients report persistent gaps. Depression itself also impairs memory, which can make it difficult to separate the effects of the illness from the effects of the treatment. Bilateral electrode placement carries a slightly higher risk of these memory effects compared to unilateral placement, which is another reason many clinicians prefer to start with unilateral.
Other common side effects include headache, muscle soreness, nausea, and temporary confusion immediately after waking from anesthesia. These are generally mild and short-lived.
Safety and Contraindications
ECT has no absolute contraindications, meaning there is no single condition that automatically disqualifies someone. Even pregnancy and having a pacemaker are not barriers to treatment. However, several conditions increase the risk and require careful evaluation: elevated pressure inside the skull (from a tumor or other mass), a recent heart attack within the past three months, severely high blood pressure, an aneurysm or malformation in the brain’s blood vessels, and acute glaucoma. In these cases, the medical team weighs the risks of the procedure against the severity of the psychiatric condition.
What Happens After the Initial Course
One of ECT’s biggest challenges isn’t getting people better; it’s keeping them better. Without any follow-up treatment, the relapse rate after a successful course of ECT is striking: 60% to 80% of patients experience a return of symptoms within the first six months.
To prevent this, doctors use two strategies. The first is medication, typically starting or adjusting antidepressants after the ECT course ends. The second is continuation or maintenance ECT, where sessions are gradually spaced out over months rather than stopped abruptly. A patient might go from three sessions per week during the acute phase to one session every few weeks, then once a month. Research from a large nationwide study found that patients who received ongoing ECT had about 30% to 50% lower risk of relapse compared to those on medication alone, and their rates of hospital readmission were significantly reduced.
Despite this evidence, maintenance ECT remains underused. Many patients and clinicians treat ECT as a one-time crisis intervention rather than an ongoing strategy, which contributes to the high relapse rates seen in clinical practice.